Cripto-3 抗体 (AA 1-50)
Quick Overview for Cripto-3 抗体 (AA 1-50) (ABIN6579613)
抗原
适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-50
- 
                                            特异性
- 
                        TDGF1P3 Antibody detects endogenous levels of TDGF1P3 protein. 
- 
                                            纯化方法
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific peptide.
- 
                                            免疫原
- The antiserum was produced against synthesized peptide derived from the Internal region of human TDGF1P3.
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB: 1:500~1:1000 ELISA: 1:10000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C/1 year
 
- 
                                            
- 
    - Cripto-3 (TDGF1P3) (Teratocarcinoma-Derived Growth Factor 1 Pseudogene 3 (TDGF1P3))
- 
                                            别名
- TDGF1P3
- 
                                            背景
- 
                        Synonyms: TDGF1P3, CRIPTO3, TDGF2, TDGF3, Putative teratocarcinoma-derived growth factor 3, Cripto-3 growth factor, Epidermal growth factor-like cripto protein CR3, Teratocarcinoma-derived growth factor 1 pseudogene 3 NCBI Gene Symbol: TDGF1P3 
- 
                                            分子量
- 21 kDa
- 
                                            OMIM
- 187395
- 
                                            UniProt
- P51864
 抗原
- 
                    
 
                                     
                                     
                                    